Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Weekly Paclitaxel Plus Oral Estramustine in Patients With Hormone Refractory Prostate Cancer

NCT00003717 is registered in ClinicalTrials.gov with St. Barnabas Medical Center as lead sponsor.

NCT NCT00003717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Weekly Paclitaxel Plus Oral Estramustine in Patients With Hormone Refractory Prostate Cancer
Lead sponsor
St. Barnabas Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 1998
Completion date
Not reported
Enrollment
17 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer